Pin1 Antibody [C4H20] | Primary Antibodies

Application: Reactivity: Human, Mouse

Usage Information

Dilution
WB1:4000 IP1:600-1:1000 IHC1:80-1:250 IF1:80-1:250

Application
WB, IP, IHC

Reactivity
Human, Mouse

Source
Mouse Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW Observed MW
18 kDa 20 kDa
^*Why do the predicted and actual molecular weights differ? The following reasons may explain differences between the predicted and actual protein molecular weight. Post-translational modifications(e.g., phosphorylation, glycosylation); Splice variants and isoforms; Relative charge; Multimerization.

Datasheet & SDS

Biological Description

Specificity
Pin1 Antibody [C4H20] detects endogenous levels of total Pin1 protein.

Clone
C4H20

Synonym(s)
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1, Peptidyl-prolyl cis-trans isomerase Pin1 (PPIase Pin1), Rotamase Pin1, PIN1

Background
Pin1 is a phosphorylation-dependent peptidyl‑prolyl cis–trans isomerase of the parvulin family that recognizes phosphorylated Ser/Thr‑Pro motifs in a wide range of regulatory proteins, positioning it as a nodal modulator of proline‑directed kinase signaling in cell proliferation, survival, and stress responses. The protein contains an N‑terminal WW domain that binds pSer/Thr‑Pro motifs and a C‑terminal catalytic PPIase domain, and the spatial arrangement of these modules allows sequential docking and isomerization of substrates to couple phosphorylation status with conformational control of downstream effectors. Pin1 forms dynamic complexes with multiple protein kinases and phosphatases, including CDKs, MAPKs, GSK3, and Cdc25 phosphatases, and by altering the conformation of specific phospho‑motifs it modulates their catalytic activity, subcellular distribution, and assembly into signaling complexes that govern cell cycle transitions and checkpoint responses. The same recognition principle extends to transcription factors and chromatin‑associated regulators such as c‑Jun, NF‑κB components, β‑catenin co‑regulators, and RNA polymerase II, where Pin1‑dependent isomerization influences promoter occupancy, cofactor recruitment, and the coupling between transcription initiation, elongation, termination, and mRNA decay. Within the transcriptional machinery, Pin1 interacts with the phosphorylated C‑terminal domain of RNAPII and factors that control promoter clearance and pause‑release, thereby shaping gene expression programs linked to proliferation, differentiation, apoptosis, and immune activation. The enzyme also engages transcriptional repressors and mRNA stability factors, so that proline‑directed phosphorylation combined with Pin1‑mediated conformational switching coordinates transcriptional output with post‑transcriptional control for sets of genes involved in cytokine production and cell fate decisions. At the protein level, Pin1 frequently regulates the balance between stabilization and degradation by influencing recognition of phosphoproteins by ubiquitin ligases or deubiquitinases, which affects steady‑state levels of key substrates such as cyclin regulators, oncogenic transcription factors, and tumor suppressor pathway components. Through this network of interactions, Pin1 integrates signals from Ras, Wnt/β‑catenin, and other oncogenic pathways, reinforcing expression and activity of drivers of cell cycle progression while modulating checkpoint and DNA damage response proteins in a phosphorylation‑ and conformation‑dependent manner. Pin1 is expressed in many tissues and operates in both nuclear and cytoplasmic compartments, where its activity is subject to control by post‑translational modifications on regulatory residues that influence substrate binding and catalytic efficiency, embedding an additional regulatory tier into signaling cascades. Dysregulated Pin1 expression and activity associate with a broad spectrum of pathologies, particularly cancer, in which elevated Pin1 enhances multiple oncogenic circuits and perturbs transcriptional homeostasis, and with neurological and immune disorders in which altered control of neuronal or inflammatory gene expression contributes to disease processes.

Background

Pin1 is a phosphorylation-dependent peptidyl‑prolyl cis–trans isomerase of the parvulin family that recognizes phosphorylated Ser/Thr‑Pro motifs in a wide range of regulatory proteins, positioning it as a nodal modulator of proline‑directed kinase signaling in cell proliferation, survival, and stress responses. The protein contains an N‑terminal WW domain that binds pSer/Thr‑Pro motifs and a C‑terminal catalytic PPIase domain, and the spatial arrangement of these modules allows sequential docking and isomerization of substrates to couple phosphorylation status with conformational control of downstream effectors. Pin1 forms dynamic complexes with multiple protein kinases and phosphatases, including CDKs, MAPKs, GSK3, and Cdc25 phosphatases, and by altering the conformation of specific phospho‑motifs it modulates their catalytic activity, subcellular distribution, and assembly into signaling complexes that govern cell cycle transitions and checkpoint responses. The same recognition principle extends to transcription factors and chromatin‑associated regulators such as c‑Jun, NF‑κB components, β‑catenin co‑regulators, and RNA polymerase II, where Pin1‑dependent isomerization influences promoter occupancy, cofactor recruitment, and the coupling between transcription initiation, elongation, termination, and mRNA decay. Within the transcriptional machinery, Pin1 interacts with the phosphorylated C‑terminal domain of RNAPII and factors that control promoter clearance and pause‑release, thereby shaping gene expression programs linked to proliferation, differentiation, apoptosis, and immune activation. The enzyme also engages transcriptional repressors and mRNA stability factors, so that proline‑directed phosphorylation combined with Pin1‑mediated conformational switching coordinates transcriptional output with post‑transcriptional control for sets of genes involved in cytokine production and cell fate decisions. At the protein level, Pin1 frequently regulates the balance between stabilization and degradation by influencing recognition of phosphoproteins by ubiquitin ligases or deubiquitinases, which affects steady‑state levels of key substrates such as cyclin regulators, oncogenic transcription factors, and tumor suppressor pathway components. Through this network of interactions, Pin1 integrates signals from Ras, Wnt/β‑catenin, and other oncogenic pathways, reinforcing expression and activity of drivers of cell cycle progression while modulating checkpoint and DNA damage response proteins in a phosphorylation‑ and conformation‑dependent manner. Pin1 is expressed in many tissues and operates in both nuclear and cytoplasmic compartments, where its activity is subject to control by post‑translational modifications on regulatory residues that influence substrate binding and catalytic efficiency, embedding an additional regulatory tier into signaling cascades. Dysregulated Pin1 expression and activity associate with a broad spectrum of pathologies, particularly cancer, in which elevated Pin1 enhances multiple oncogenic circuits and perturbs transcriptional homeostasis, and with neurological and immune disorders in which altered control of neuronal or inflammatory gene expression contributes to disease processes.

References
https://pubmed.ncbi.nlm.nih.gov/32266261/ https://pubmed.ncbi.nlm.nih.gov/36496344/

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%